Brought to you by 
Avila to use its Avilomics platform in Sanofi deal
21 Dec 2010
Executive Summary
Avila Therapeutics Inc. (cancer, infectious diseases, and autoimmune disorders) will use its Avilomics informatics drug discovery platform to identify new candidates for Sanofi-Aventis.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Drug Discovery Tools
- Bioinformatics
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Avila to use its Avilomics platform in Sanofi deal
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice